Systemic lupus erythematosus: genes and variants
Explore variant evidence for Systemic lupus erythematosus across 12 analyzed proteins (TLR7, TREX1, CTLA4, STAT4, IFNAR1 and 7 more). Linked ClinVar records include 3 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 7 with conflicting classifications.
Coverage includes proteins already analyzed in CATVariant, not every gene involved in this condition. Database links are associations, not an assessment of clinical gene–disease validity. Computable evidence prioritizes variants for expert review and does not reclassify them. Source labels are pooled across this disease family.
Data updated 2026-10-21. Automated aggregation, not a clinical review date.
Download variant evidence (CSV)
Genes linked to Systemic lupus erythematosus
TLR7: Toll-like receptor 7
It detects single-stranded viral RNA in endosomes and drives type I interferon and inflammatory responses, particularly in plasmacytoid dendritic cells and B cells. Loss-of-function variants can predispose to severe viral infection, whereas gain-of-function variants cause immune dysregulation and autoimmunity.
1 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in TLR7 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
TREX1: Three-prime repair exonuclease 1
It degrades aberrant cytosolic DNA and prevents inappropriate activation of the cGAS-STING interferon pathway. Pathogenic variants cause interferon-mediated diseases including Aicardi-Goutieres syndrome and familial chilblain lupus, and certain alleles cause retinal vasculopathy with cerebral leukoencephalopathy.
0 ClinVar pathogenic / likely pathogenic and 7 uncertain variants in TREX1 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
CTLA4: Cytotoxic T-lymphocyte protein 4
It restrains T-cell activation by competing with CD28 for CD80 and CD86 and by delivering inhibitory signals after immune activation. Haploinsufficiency causes immune dysregulation with autoimmunity and lymphoproliferation, while therapeutic blockade enhances antitumor immunity.
0 ClinVar pathogenic / likely pathogenic and 2 uncertain variants in CTLA4 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
STAT4: Signal transducer and activator of transcription 4
It transduces signals from IL-12 and related cytokines to promote Th1 differentiation and IFN-gamma production. Common variants strongly influence susceptibility to autoimmune diseases such as rheumatoid arthritis and systemic lupus erythematosus.
0 ClinVar pathogenic / likely pathogenic and 1 uncertain variants in STAT4 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
IFNAR1: Interferon alpha/beta receptor 1
Together with IFNAR2, it detects type I interferons and activates JAK-STAT antiviral and immunoregulatory programs. Loss-of-function can impair antiviral defense, while excessive pathway activation contributes to interferon-driven inflammatory disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IFNAR1 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
IL10: Interleukin-10
It suppresses excessive inflammatory cytokine production and restrains antigen-presenting cells and effector lymphocytes, protecting tissues from immune-mediated damage. Loss of IL-10 signaling causes severe early-onset intestinal inflammation and inflammatory bowel disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in IL10 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
NCF2: Neutrophil cytosol factor 2
It helps activate the phagocyte NADPH oxidase by assembling with membrane and cytosolic partners during the respiratory burst. Biallelic loss-of-function variants cause chronic granulomatous disease and impaired killing of catalase-positive bacteria and fungi.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in NCF2 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
PTPN22: Tyrosine-protein phosphatase non-receptor type 22
It tunes antigen-receptor signaling thresholds in T and B cells and helps maintain immune tolerance. The common R620W variant is a major non-HLA genetic risk factor for several autoimmune diseases, including type 1 diabetes and rheumatoid arthritis.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in PTPN22 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
TLR9: Toll-like receptor 9
It detects unmethylated CpG-rich DNA in endosomes and activates innate immune and type I interferon responses. Dysregulated signaling can contribute to autoimmunity, while agonists and antagonists of the pathway are being developed for cancer and inflammatory disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TLR9 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
TNFAIP3: Tumor necrosis factor alpha-induced protein 3
Its A20 ubiquitin-editing activity terminates NF-kappaB signaling after inflammatory receptor activation and helps prevent excessive immune responses. Haploinsufficiency causes early-onset autoinflammatory disease, while somatic loss occurs in several lymphoid malignancies.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TNFAIP3 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
TYK2: Non-receptor tyrosine-protein kinase TYK2
It transmits signals from type I interferon, IL-12, IL-23, and related cytokine receptors. Severe loss-of-function can cause immunodeficiency, common variants influence autoimmune susceptibility, and partial pharmacologic inhibition is effective in inflammatory disease.
0 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in TYK2 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
SOCS1: Suppressor of cytokine signaling 1
It provides inducible negative feedback on cytokine signaling by inhibiting JAK kinases and promoting degradation of signaling components. Haploinsufficiency can cause early-onset autoimmunity and immune dysregulation, while somatic loss contributes to some lymphomas.
2 ClinVar pathogenic / likely pathogenic and 0 uncertain variants in SOCS1 have source records linked to Systemic lupus erythematosus. Association strength is not clinical gene validity.
ClinVar pathogenic and likely pathogenic variants linked to Systemic lupus erythematosus
| Variant | Position | Protein part | Clinical label |
|---|---|---|---|
| SOCS1 Y154H | 154 | SH2 | Pathogenic / likely pathogenic |
| TLR7 F507L | 507 | LRR 16 | Pathogenic / likely pathogenic |
| SOCS1 R22W | 22 | Pathogenic / likely pathogenic |
Diseases related to Systemic lupus erythematosus
- Type 1 diabetes mellitus, also linked to CTLA4, IL10, PTPN22 and TYK2
- Crohn disease, also linked to IL10, PTPN22 and TYK2
- Hypothyroidism, also linked to CTLA4, PTPN22 and TYK2
- Malaria, also linked to TLR7 and TLR9
- Basal cell carcinoma, also linked to CTLA4 and TLR7
- Melanoma, also linked to CTLA4 and IFNAR1
- Diabetes mellitus, also linked to PTPN22
- Non-small cell lung carcinoma, also linked to CTLA4
- Autoimmune lymphoproliferative syndrome due to CTLA4 haploinsufficiency, also linked to CTLA4
- Inherited Immunodeficiency Diseases, also linked to CTLA4
- Fetal anomalies with a likely genetic cause, also linked to TREX1
- Hyperthyroidism, also linked to CTLA4
Frequently asked questions
Which genes have records linked to Systemic lupus erythematosus?
This view contains 12 analyzed proteins: TLR7, TREX1, CTLA4, STAT4, IFNAR1 and 7 more. Links come from clinical records and association databases. They do not imply that every listed gene is a validated cause, and missing genes may not yet be analyzed.
What do the clinical classifications mean?
Linked records include 3 pathogenic or likely pathogenic variants, 5 variants of uncertain significance and 7 with conflicting classifications. Labels summarize source records; multi-condition records may not make a separate assertion for this disease. Check the original record and review status.
Does the evidence score change a VUS classification?
No. 0 VUS or conflicting variants reach the likely-pathogenic points range on the computable criteria available here. This is a research prioritization signal, not a clinical classification. Patient, family and other required evidence may be missing.
Can I download the variant evidence?
Download the CSV for all 27 variants in the selected disease scope, including clinical labels, review status, evidence criteria, predictor scores, functional measurements and population frequency where available.
About this data
Variant–disease links come from ClinVar, Open Targets and UniProt, pooled from eligible public CATVariant analyses of each human protein. Evidence scores use the ACMG/AMP Bayesian points scale with computable criteria only (position among known disease variants, rarity in gnomAD, calibrated predictors, deep mutational scanning); there is no family or patient data, so they prioritise variants for expert review and never classify them.
Download every variant as CSV · Browse all diseases · Methods · About the Center